[Replacement of infected knee and hip endoprostheses].
Infections occur in 0.5-5% of cases after implantation of an endoprosthesis and represent one of the most severe complications of artificial joint replacements. Approximately 300,000 primary implantations for hip and knee prostheses are carried out in Germany annually with a corresponding number of early and late infections. This means that approximately 4,000-6,000 cases are to be expected annually. Periprosthetic infections normally lead to a significant loss of function and quality of life for patients and the complex remediation is costly. Therefore, preventive measures, such as perioperative prophylaxis with antibiotics, maintaining highly sterile conditions during operations and an expedient selection of patients are of substantial importance. The basic principles of an adequate restoration include identification of the pathogen, local eradication of the infection mostly after removal of the prosthesis, pathogen-oriented systemic and local antibiotic therapy and finally re-implantation of the revision prosthesis under infection-free conditions. The standard procedure for revision surgery is a two-phase replacement with maintenance of an infection-free interval before renewal of the prosthesis. The use of single-phase or multi-phase strategies, as well as the selection of cemented or cement-free revision, varies between centers as a definitive evaluation is not yet available.The most important parameters for successful treatment of periprosthetic infections have been identified as the earliest possible diagnosis, radical surgical cleansing with an adequate antibiotic therapy and successful restoration has been reported in approximately 80% of cases. Because of the complex therapy regime, treatment in specialized centers is generally recommended especially under the aspect of a demanding patient monitoring.
Militz
M
M
BG Unfallklinik Murnau, Prof.-Küntscher-Strasse 8, Murnau, Germany. mmilitz@bgu-murnau.de
Bühren
V
V
D000465:Algorithms; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D020878:Device Removal; D042241:Early Diagnosis; D019544:Equipment Failure Analysis; D006622:Hip Prosthesis; D006801:Humans; D007720:Knee Prosthesis; D016459:Prosthesis-Related Infections / Q000175:diagnosis / Q000517:prevention & control / Q000601:surgery*; D012086:Reoperation
D000900:Anti-Bacterial Agents